PSW-1025
- Generic Name
- PSW-1025
Clinical Trial of Targeted Alpha Therapy Using [At-211]PSMA-5 for Prostate Cancer
- First Posted Date
- 2024-06-04
- Last Posted Date
- 2024-07-23
- Lead Sponsor
- Osaka University
- Target Recruit Count
- 15
- Registration Number
- NCT06441994
- Locations
- 🇯🇵
Osaka University Hospital, Suita, Osaka, Japan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath